Moreover, IL-34 deficiency was shown to be an independent adverse prognostic factor for patients with LUAD, and subgroup analysis indicated that IL-34 might contribute to the stratified management of patients with LUAD. This evidence concerns the gene IL34 and hyperinsulinemic hypoglycemia, familial, 4.